Do Life Insurers Test for Hepatitis C?
Most life insurance applications require a medical exam that includes blood work. The panel typically tests for hepatitis B surface antigen, hepatitis C antibody, and sometimes hepatitis C RNA. If you are a candidate for a standard policy, the insurer will screen for Hep C to assess your health risk and determine underwriting eligibility.
More from this site
Keep reading the latest coverage
Interpreting a Positive Hep C Antibody Test
A positive antibody result indicates past or current exposure, not necessarily an active infection. Insurers differentiate between a cleared infection, a chronic carrier state, or a recent positive result that may still be in the window period. A chronic Hep C infection often leads to higher premiums or coverage denial unless the viral load is undetectable and liver function tests are normal.
How a Diagnosis Affects Policy Terms
If a medical examiner confirms active Hep C infection, the insurer may offer a reduced‑term policy, impose a higher premium, or exclude coverage for liver‑related claims. Some carriers have a "no‑question" policy for certain pre‑existing conditions, but this varies widely. In many cases, a pre‑existing condition waiver can be obtained by providing recent liver function tests and a treatment plan.
Preparing Your Application
Gather recent laboratory reports: hepatitis C RNA, liver enzymes (ALT, AST), and imaging if available. Be prepared to discuss treatment history, adherence to antiviral therapy, and current viral load. Providing a documented clearance from a hepatologist can improve your chances of favorable underwriting.
Alternative Options If Denied
Consider a high‑risk or guaranteed issue policy, which usually has higher premiums but accepts applicants with chronic illnesses. Some state‑based programs offer subsidized coverage for individuals with medical conditions. Additionally, a life insurance broker specializing in high‑risk applicants can shop for carriers that offer more flexible underwriting for Hep C cases.